ITEOS THERAPEUTICS INC (ITOS) Stock Earnings & Estimates
USA - NASDAQ:ITOS - US46565G1040 - Common Stock
10.15 USD
+0.02 (+0.2%)
10.17 USD
+0.02 (+0.2%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 267.6M -22.39% | 12.595M -95.29% | 35M 177.89% | -100.00% | 6.884M | -100.00% | 3.337M | 357K -89.30% | 6.324M 1,671.43% | |||
| EBITDA YoY % growth | 127.1M -48.23% | -150.203M -218.18% | -158.29M -5.38% | -125.46M 20.74% | -95.88M 23.58% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 126.3M -48.43% | -151.101M -219.64% | -159.528M -5.58% | -179.905M -12.77% | -104.5M 41.91% | -169.098M -61.82% | -164.64M 2.64% | -167.405M -1.68% | -170.272M -1.71% | -92.099M 45.91% | -97.569M -5.94% | |
| Operating Margin | 47.20% | -1,199.69% | -455.79% | N/A | -1,518.01% | N/A | N/A | N/A | -5,102.54% | -25,798.00% | -1,542.84% | |
| EPS YoY % growth | N/A -50.69% | -3.15 -213.87% | -3.33 -5.71% | -3.58 -7.51% | -2.08 41.81% | -1.84 11.75% | -2.72 -48.13% | -2.73 -0.37% | -2.76 -0.93% | -2.33 15.71% | -2.23 3.95% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.18 -12.10% | -0.43 58.74% | -0.49 38.16% | -0.54 62.02% | -0.56 52.56% | -0.51 -20.00% | -0.05 89.69% | -0.05 90.42% | -0.05 90.32% | -0.06 89.00% |
| Revenue Q2Q % growth | N/A | N/A | 4.709M | N/A | ||||||
| EBITDA Q2Q % growth | -22.44M 53.13% | -22.44M 53.34% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -54.746M -12.19% | -25.24M 48.84% | -17.724M 63.40% | -18.354M 72.79% | -18.482M 66.24% | -19.127M 24.22% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -1.43 -694.44% | -1.03 | -0.40 | -39.15% |
| Q1 2025 Q2Q % growth | -0.80 25.23% | -0.97 | 0.17 | 17.53% |
| Q4 2024 Q2Q % growth | -1.03 -21.18% | -1.09 | 0.06 | 5.09% |
| Q3 2024 Q2Q % growth | -1.05 -16.67% | -0.91 | -0.14 | -15.79% |
| Q2 2024 Q2Q % growth | -0.18 81.25% | -1.06 | 0.88 | 82.99% |
| Q1 2024 Q2Q % growth | -1.07 -143.18% | -1.28 | 0.21 | 16.49% |
| Q4 2023 Q2Q % growth | -0.85 -349.75% | -1.05 | 0.20 | 19.34% |
| Q3 2023 Q2Q % growth | -0.90 -3,100.00% | -1.23 | 0.33 | 26.68% |
| Q2 2023 Q2Q % growth | -0.96 -740.00% | -1.05 | 0.09 | 8.62% |
| Q1 2023 Q2Q % growth | -0.44 -124.18% | -1.01 | 0.57 | 56.62% |
| Q4 2022 Q2Q % growth | -93.04% | 0.34 | % | |
| Q3 2022 Q2Q % growth | 0.03 -98.39% | 0.10 | -0.07 | -69.83% |
| Q2 2022 Q2Q % growth | 0.15 120.00% | 1.23 | -1.08 | -87.77% |
| Q1 2022 Q2Q % growth | 1.82 566.67% | 0.81 | 1.01 | 124.44% |
| Q4 2021 Q2Q % growth | 4.89 1,237.21% | 1.30 | 3.59 | 275.13% |
| Q3 2021 Q2Q % growth | 1.86 487.50% | 5.05 | -3.19 | -63.18% |
| Q2 2021 Q2Q % growth | -0.75 97.46% | -0.42 | -0.33 | -77.61% |
| Q1 2021 Q2Q % growth | -0.39 | -0.49 | 0.10 | 20.01% |
| Q4 2020 Q2Q % growth | -0.43 | -0.43 | 0.00 | 0.22% |
| Q3 2020 Q2Q % growth | -0.48 | -0.37 | -0.11 | -29.28% |
| Q2 2020 Q2Q % growth | -29.49 | -0.48 | -29.01 | -6,084.33% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -100.00% | % | ||
| Q1 2025 Q2Q % growth | 1.836M | -1.836M | -100.00% | |
| Q3 2024 Q2Q % growth | 17M | -17M | -100.00% | |
| Q2 2024 Q2Q % growth | 35M | 1.02M | 33.98M | 3,331.37% |
| Q1 2024 Q2Q % growth | -100.00% | % | ||
| Q4 2023 Q2Q % growth | -100.00% | % | ||
| Q3 2023 Q2Q % growth | -100.00% | % | ||
| Q2 2023 Q2Q % growth | -100.00% | % | ||
| Q1 2023 Q2Q % growth | 12.595M -91.74% | 8.199M | 4.396M | 53.62% |
| Q4 2022 Q2Q % growth | 53.9M -77.59% | 41.979M | 11.921M | 28.40% |
| Q3 2022 Q2Q % growth | 19.5M -81.30% | 42.889M | -23.389M | -54.53% |
| Q2 2022 Q2Q % growth | 41.7M | 87.269M | -45.569M | -52.22% |
| Q1 2022 Q2Q % growth | 152.5M | 64.566M | 87.934M | 136.19% |
| Q4 2021 Q2Q % growth | 240.5M | 87.168M | 153.332M | 175.90% |
| Q3 2021 Q2Q % growth | 104.3M | 164.35M | -60.05M | -36.54% |
| Q2 2021 Q2Q % growth | 3.984M | -3.984M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -6.61% | -10.11% | -10.29% | -1.39% |
| Revenue | N/A | N/A | N/A | -100% |